2020 - 2022 Correlation analysis of receptor binding rate and efficacy or side effects of Immune checkpoint inhibitors of PD-L1
Papers (27):
Toshiaki Tsurui, Yuya Hirasawa, Yutaro Kubota, Kiyoshi Yoshimura, Takuya Tsunoda. Anti-EGFR antibody monotherapy for colorectal cancer with severe hyperbilirubinemia: A case report. World journal of gastrointestinal oncology. 2024. 16. 2. 557-562
Masahiro Hosonuma, Yuya Hirasawa, Atsuo Kuramasu, Masakazu Murayama, Yoichiro Narikawa, Hitoshi Toyoda, Yuta Baba, Junya Isobe, Eiji Funayama, Kohei Tajima, et al. Nivolumab receptor occupancy on effector regulatory T cells predicts clinical benefit. Cancer science. 2024